Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality in patients with prediabetes and type 2 diabetes mellitus (T2DM). Carnosine has been suggested as a potential approach to reduce ASCVD risk factors. However, there is a paucity of human data. Hence, we per...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadati, Saeede, Cameron, James, Menon, Kirthi, Hodge, Alexander, Lu, Zhong X., de Courten, Maximilian, Feehan, Jack, de Courten, Barbora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674211/
https://www.ncbi.nlm.nih.gov/pubmed/38004228
http://dx.doi.org/10.3390/nu15224835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674211/
https://www.ncbi.nlm.nih.gov/pubmed/38004228
http://dx.doi.org/10.3390/nu15224835

Ejemplares similares